The Bulletin
The Times


.

Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I I Conditions and U.S. FDA Clearance of IND Application for BBT001

  • Written by PR Newswire
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I I Conditions and U.S. FDA Clearance of IND Application for BBT001
  • Preclinical data with BBT002 demonstrate its best-in-disease potential for improved efficacy and dosing convenience across respiratory, dermatology, and gastroenterology indications
  • Interim safety and pharmacokinetic data from BBT002-01 study anticipated in Q1 2026
  • The clearance of BBT001-01 study expands the clinical development territory of BBT001...

The Bulletin Magazine

Executive Recruitment for Education Leadership: What Schools Should Consider

Practical Guide to Roller Shutters for Safer, More Comfortable Homes

Why the Advertised Rate on a Bonus Saver Account Isn't What Most Savers Actually Earn

The Essential Bathroom Renovation Supplies Checklist Before You Start

Pull Up Stands: A Convenient Display Option for Events and Promotions

How Mining Hose Selection Can Improve Material Transfer Systems

Electric Sliding Door: What to Consider Before Choosing One

What Is Included in a Professional Roof Repair Service on the Gold Coast?

The Unglamorous Baby Buys That Save Australian Parents the Most Time

Cryptocurrency Trading in 2026_ Why Regulated Education Is the New Standard

How Mining Hose Routing Can Influence Wear and Transfer Efficiency

Cryotherapy in Melbourne: What Skin Lesions Can Be Treated with Targeted Cold Therapy?

hacklink hack forum hacklink film izle hacklink Galabetjojobetjojobetjojobetcasinos not on gamstopnon uk casinosnot on gamstopcasinos not on gamstopcasinos non gamblock ukiptv satın aliptv satın alzlibraryzlibraryz-libraryIQOSdeneme bonusuPadişahbetvippark kayıtPadişahbetdeneme bonusulunabet girişPadişahbettaraftarium24Sahabet girişjojobetjojobetjojobetviljo kasinot kirjautuminenGalabetzimpler kasinotGalabet1xbetjojobet girişcasibomcasibombetparkmatbetmatbetjojobet